BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 10933900)

  • 1. Glycine(B) receptor antagonists and partial agonists prevent memory deficits in inhibitory avoidance learning.
    Viu E; Zapata A; Capdevila J; Skolnick P; Trullas R
    Neurobiol Learn Mem; 2000 Sep; 74(2):146-60. PubMed ID: 10933900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells.
    Viu E; Zapata A; Capdevila JL; Fossom LH; Skolnick P; Trullas R
    J Pharmacol Exp Ther; 1998 May; 285(2):527-32. PubMed ID: 9580593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory avoidance memory deficit induced by scopolamine: Interaction of cholinergic and glutamatergic systems in the ventral tegmental area.
    Mahmoodi G; Ahmadi S; Pourmotabbed A; Oryan S; Zarrindast MR
    Neurobiol Learn Mem; 2010 Jul; 94(1):83-90. PubMed ID: 20403448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory avoidance memory deficit induced by scopolamine: interaction with glutamatergic system in the nucleus accumbens.
    Pakpour B; Ahmadi S; Nayer-Nouri T; Oryan S; Zarrindast MR
    Behav Pharmacol; 2010 Dec; 21(8):719-26. PubMed ID: 20926947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of NMDA receptors in the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice.
    Almasi-Nasrabadi M; Javadi-Paydar M; Mahdavian S; Babaei R; Sharifian M; Norouzi A; Dehpour AR
    Behav Brain Res; 2012 May; 231(1):138-45. PubMed ID: 22440233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures.
    Boje KM; Wong G; Skolnick P
    Brain Res; 1993 Feb; 603(2):207-14. PubMed ID: 8096423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of (+)-HA-966, CGS-19755, phencyclidine, and dizocilpine on repeated acquisition of response chains in pigeons: systemic manipulation of central glycine sites.
    Campbell CM; Butelman ER; Woods JH
    J Pharmacol Exp Ther; 1999 Apr; 289(1):521-7. PubMed ID: 10087045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic dosing with 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, modulates NMDA inhibition of muscarinic-coupled PI hydrolysis in rat cortical slices.
    Boje KM; Lakhman SS
    Neurochem Res; 1998 Sep; 23(9):1167-74. PubMed ID: 9712186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits.
    Smothers CT; Woodward JJ
    J Pharmacol Exp Ther; 2007 Aug; 322(2):739-48. PubMed ID: 17502428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.
    Ohtani K; Tanaka H; Yoneda Y; Yasuda H; Ito A; Nagata R; Nakamura M
    Brain Res; 2002 Jul; 944(1-2):165-73. PubMed ID: 12106676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricular infusion of the NMDA receptor-associated glycine site antagonist 7-chlorokynurenate impairs water maze performance but fails to block hippocampal long-term potentiation in vivo.
    Bannerman DM; Butcher SP; Good MA; Morris RG
    Neurobiol Learn Mem; 1997 Nov; 68(3):252-70. PubMed ID: 9398588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of NMDA receptor glycine site antagonists on hypoxia-induced neurodegeneration of rat cortical cell cultures.
    Priestley T; Horne AL; McKernan RM; Kemp JA
    Brain Res; 1990 Oct; 531(1-2):183-8. PubMed ID: 2149665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
    Widdowson PS; Gyte AJ; Upton R; Wyatt I
    Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
    Priestley T; Marshall GR; Hill RG; Kemp JA
    Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glycine/NMDA receptor antagonist HA-966 impairs visual recognition memory in rhesus monkeys.
    Matsuoka N; Aigner TG
    Brain Res; 1996 Aug; 731(1-2):72-8. PubMed ID: 8883856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N-methyl-D-aspartate receptors.
    Nahum-Levy R; Fossom LH; Skolnick P; Benveniste M
    Mol Pharmacol; 1999 Dec; 56(6):1207-18. PubMed ID: 10570048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the basolateral amygdala NMDA and muscarinic receptors in rat's memory retrieval.
    Nazarinia E; Rezayof A; Sardari M; Yazdanbakhsh N
    Neurobiol Learn Mem; 2017 Mar; 139():28-36. PubMed ID: 27993648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of NMDA glutamate receptor antagonist drugs on the volitional consumption of ethanol by a genetic drinking rat.
    McMillen BA; Joyner PW; Parmar CA; Tyer WE; Williams HL
    Brain Res Bull; 2004 Sep; 64(3):279-84. PubMed ID: 15464866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different modes of action of 3-amino-1-hydroxy-2-pyrrolidone (HA-966) and 7-chlorokynurenic acid in the modulation of N-methyl-D-aspartate-sensitive glutamate receptors.
    Danysz W; Fadda E; Wroblewski JT; Costa E
    Mol Pharmacol; 1989 Dec; 36(6):912-6. PubMed ID: 2574820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
    Wlaź P
    Brain Res Bull; 1998 Aug; 46(6):535-40. PubMed ID: 9744291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.